Clinical Trials Logo

Headache clinical trials

View clinical trials related to Headache.

Filter by:

NCT ID: NCT03385174 Completed - Headache Disorders Clinical Trials

Carbon Monoxide Headache Triggering Properties as Well as Effects on the Brain's Vessels and Blood Flow

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

Studying Carbon monoxide effects on brain vessels in healthy volunteers with magnetic resonance imaging.

NCT ID: NCT03359252 Completed - Headache Clinical Trials

Headache After Coil Embolization for Unruptured Intracranial Aneurysms

Start date: June 5, 2018
Phase: N/A
Study type: Interventional

Perform a prospective cohort study to compare the incidence and severity of headache between non-stent assisted coiling and stent assisted coiling of unruptured intracranial aneurysms.

NCT ID: NCT03347188 Completed - Clinical trials for Post-Traumatic Headache

A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)

Start date: December 18, 2017
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of fremanezumab in adult participants aged 18 to 70 years, inclusive, for the prevention of PTH. The study will include a double-blind (DB) treatment period (12 weeks) and an open-label (OL) treatment period (12 weeks).

NCT ID: NCT03346252 Completed - Clinical trials for Secondary Headache Disorder

The Effect of Botulinum Toxin A on Headache Attributed to TMD

Start date: May 8, 2017
Phase: Early Phase 1
Study type: Interventional

This study will evaluate the effect of of botulinum toxin on the treatment of Headache Attributed to TMD.

NCT ID: NCT03341689 Completed - Migraine Headache Clinical Trials

Psilocybin for the Treatment of Migraine Headache

Start date: November 1, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the effects of oral psilocybin in migraine headache. Subjects will each receive a dose of placebo and a dose of psilocybin approximately 14 days apart. Subjects will be randomized to the order of treatment and they will be randomized to receive either low or high dose psilocybin. Subjects will maintain a headache diary prior to, during, and after the treatments in order to document headache frequency and intensity, as well as associated symptoms. This preliminary study will inform on the basic effects of psilocybin in migraine headache and inform on the design of larger, more definitive studies.

NCT ID: NCT03337620 Completed - Headache, Migraine Clinical Trials

Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine

Start date: September 20, 2017
Phase: Phase 3
Study type: Interventional

This is a double blind placebo-controlled study which will evaluate the efficacy of bupivacaine compared to saline, delivered by the Tx360® device to the sphenopalatine ganglion (SPG), to treat chronic migraine headache. The Tx360® is a nasal applicator which is cleared through the FDA for transnasal medication delivery, including delivery to the SPG. The SPG has been implicated in a variety of cephalalgias. It is critical to the success of this intervention that the blocking agent be accurately delivered to this area as it is the only non-bony access to the pterygopalatine fossa (PPF). Subjects meeting inclusion/exclusion criteria will receive 12 intranasal treatments to the SPG over a period of 4 weeks with follow-up monthly for an additional 3 months post-treatment.

NCT ID: NCT03314584 Completed - Clinical trials for Traumatic Brain Injury (TBI)

Managing MTBI-related Headaches With rTMS

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Persistent headache is one of the most common debilitating symptoms in military personnel suffering from mild traumatic brain injury (MTBI). This study aims to assess the long-term effect of repetitive transcranial magnetic stimulation (rTMS) in managing MTBI related headaches for up to 2-3 months by comparing the treatment effect of active-rTMS to sham-rTMS.

NCT ID: NCT03308630 Completed - Headache Clinical Trials

Immediate Effect of Energy Alignment and Mantra on Stress Related Pain in Adolescents

Start date: June 28, 2017
Phase: N/A
Study type: Interventional

Psychiatrists have expressed concern at the emergence of education as a serious source of stress for school-going children - causing high incidence of deaths by suicide. Many adolescents in India are referred to hospital psychiatric units for school-related distress - exhibiting symptoms of depression, high anxiety, frequent school refusal, phobia, physical complaints, irritability, weeping spells, and decreased interest in school work. Previous studies have found significant anxiety, distress, depression, worn outs and severe impact of psychological factors on the performances of dental, engineering and medical student. But students preparing for competitive exams have not been studied yet. Current study reports the scientific evidence of immediate effect of yoga based techniques combined with music and Vedic chants on adolescents preparing for competitive exams.

NCT ID: NCT03304886 Completed - Headache Disorders Clinical Trials

Assessing the Diagnostic Accuracy of an On-line Questionnaire for Diagnosis of Primary Headache Disorders

Start date: February 28, 2018
Phase:
Study type: Observational

Purpose of the study is to assess the diagnostic accuracy of an on- line questionnaire in comparison to a semi-structured interview administered by a trained interviewer.

NCT ID: NCT03277859 Completed - Clinical trials for Traumatic Brain Injury

Strength and Awareness in Action: an Intervention for Post-Acute TBI Headaches (SAA-TBI)

SAA-TBI
Start date: August 16, 2017
Phase: N/A
Study type: Interventional

The specific aims of the proposed study are to evaluate: 1) the feasibility of design elements of a Strength and Awareness in Action: an Intervention for Post-Acute TBI Headaches (SAA-TBI) intervention trial (e.g., an exercise run-in to facilitate participant retention); 2) yoga instructor fidelity; and 3) variability estimates for candidate proximal and distal outcomes. Performance of validated measures, including those associated with quality of life, as well as data collected via ecological momentary assessment and pedometry (physical activity) will be evaluated.